HMGB1 suppression confers neuroprotection against stroke in diabetic rats
Open Access
- 1 December 2013
- journal article
- Published by Walter de Gruyter GmbH in Translational Neuroscience
- Vol. 4 (4) , 477-483
Abstract
Article HMGB1 suppression confers neuroprotection against stroke in diabetic rats was published on December 1, 2013 in the journal Translational Neuroscience (volume 4, issue 4).Keywords
This publication has 29 references indexed in Scilit:
- Diabetes, hyperglycaemia, and acute ischaemic strokeThe Lancet Neurology, 2012
- HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammationExpert Opinion on Therapeutic Targets, 2011
- Hyperglycaemia and Infarct Size in Animal Models of Middle Cerebral Artery Occlusion: Systematic Review and Meta-AnalysisJournal of Cerebral Blood Flow & Metabolism, 2010
- Hyperglycemia, diabetes and stroke: Focus on the cerebrovasculatureVascular Pharmacology, 2009
- Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLEJournal of Experimental Medicine, 2008
- Moderate hyperglycaemia is associated with favourable outcome in acute lacunar strokeBrain, 2007
- Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic PatientsStroke, 2001
- HMG-1 as a Late Mediator of Endotoxin Lethality in MiceScience, 1999
- Perfusion Deficit Parallels Exacerbation of Cerebral Ischemia/Reperfusion Injury in Hyperglycemic RatsJournal of Cerebral Blood Flow & Metabolism, 1997
- The long term efficacy of glycyrrhizin in chronic hepatitis C patientsCancer, 1997